Provider Knowledge of 2013 Cystic Fibrosis Infection Prevention and Control Guidelines for Outpatient Care
Cindy L Williams1, Maria Ansar2, Juyan J Zhou3
1Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Pediatric Pulmonology
|December 26, 2025
Summary
Staff in cystic fibrosis (CF) clinics are aware of infection prevention and control (IP&C) policies but need better knowledge of specific practices. The COVID-19 pandemic increased adherence to some IP&C measures.
Area of Science:
- Infectious Diseases
- Pulmonology
- Healthcare Management
Background:
- Chronic lung infections are common in cystic fibrosis (CF) and transmissible among patients.
- The 2013 Cystic Fibrosis Foundation (CFF) guidelines updated infection prevention and control (IP&C) recommendations.
- Assessing staff knowledge and barriers to IP&C implementation is crucial for patient safety.
Purpose of the Study:
- Evaluate staff knowledge of 2013 CFF IP&C recommendations in outpatient CF clinics.
- Identify barriers to implementing these IP&C practices.
- Determine practice changes related to IP&C during the COVID-19 pandemic.
Main Methods:
- A multicenter study involving 20 CF centers (10 pediatric, 10 adult).
- Anonymous electronic surveys distributed to outpatient clinical care teams.
- Data collected between May and November 2022.
Main Results:
- 174 respondents from diverse healthcare professions participated.
- Awareness of written CF IP&C policies was high (72.4%), but knowledge of specific cleaning roles was lower (50.8%).
- Adherence to spirometry recommendations was high (77.1%), with perceived increases in personal protective equipment use and hand hygiene post-pandemic.
Conclusions:
- Awareness of CF infection prevention and control policies has increased since 2013.
- Specific knowledge regarding IP&C practices requires improvement among CF clinical staff.
- The COVID-19 pandemic may have positively influenced adherence to certain IP&C measures.
Related Concept Videos
Cystic Fibrosis: Management
438
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
438
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Standard Precaution
2.7K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.7K
Transmission-based Precautions I: Contact, Enteric, and Droplets
4.4K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.4K
Transmission-based Precautions II: Airborne and Protective Environment
1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K
Cystic Fibrosis: Pathogenesis
676
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
676


